πŸ“Š This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: ADx Neurosciences

1.1 - Company Overview

ADx Neurosciences Logo

ADx Neurosciences

Headquarter: Belgium
Founded: 20XXπŸ”’
Employees: 100-500πŸ”’
🌐 Website

Company description

  • Provider of proprietary biomarker assays and antibody solutions for neurodegenerative diseases, enabling early detection of Alzheimer’s, Parkinson’s and traumatic brain injury. Delivers custom and monoclonal antibodies (Amyloid-beta, Tau, Synuclein), pharma and IVD solutions from antibody to qualified assay and automated kits, and co-develops commercial immunoassays for clinical and drug development.

Products and services

  • Biomarker Assays: State-of-the-art assays quantify Alzheimer’s, Parkinson’s, and traumatic brain injury biomarkers, enabling early detection and supporting drug development and clinical practice
  • IVD Solutions: Automated-platform-ready services supply antibodies and continuous support to develop and implement assays into easy-to-use kits for automated platforms serving pharmaceutical companies and clinics
  • Pharma Solutions: IVD-qualified programs develop biomarkers from antibody to qualified assay for in vitro diagnostic use, supporting drug development with robust and scalable assays

Key contacts

πŸ”’
πŸ”’

Financial details

πŸ”’

1.2 - Competitors and similar companies to ADx Neurosciences

Rapport Therapeutics Logo

Rapport Therapeutics

HQ: United States Website
  • Description: Provider of precision medicines for neurological disorders, leveraging a RAP Technology Platform to discover and develop small-molecule therapies targeting specific neuronal receptor complexes. Programs include TARPΞ³8 AMPAR small molecules in clinical development for epilepsy with potential in pain and bipolar disorder, and discovery-stage nAChR modulators for chronic pain and hearing disorders.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Rapport Therapeutics company profile β†’
Nautilus Neurosciences Logo

Nautilus Neurosciences

HQ: United States Website
  • Description: Provider of specialty pharmaceutical products and services for the treatment of neurological disorders.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nautilus Neurosciences company profile β†’
Cosman Medical Logo

Cosman Medical

HQ: United States Website
  • Description: Provider of radiofrequency (RF) generators, electrodes, and cannulae for neurosurgery and pain management in interventional anesthesiology and podiatry, leveraging RF nerve ablation with a 60-year track record in medicine.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cosman Medical company profile β†’
Claret Medical Logo

Claret Medical

HQ: United States Website
  • Description: Provider of cerebral vascular protection systems for transcatheter aortic valve implantation (TAVI), surgical, and other interventional procedures, including Claret Medical Montage, a percutaneously delivered dual-filter embolic protection device to capture and remove dislodged debris.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Claret Medical company profile β†’
Psyadon Logo

Psyadon

HQ: United States Website
  • Description: Provider of discovery and development of new treatments for serious psychiatric and neurological diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Psyadon company profile β†’
πŸ”’

2.M&A buyers

2.1 Potential strategic acquirers in the sector

πŸ”’
πŸ”’
πŸ”’
πŸ”’ View all strategic buyers with complete profiles
Start Free Trial β†’

2.2 - Strategic buyer groups for ADx Neurosciences

πŸ”’

Buyer group 1: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ

●● companies
Description: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
Key Products: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
πŸ”’ View all companies in this group
Request Free Trial Now β†’
πŸ”’

Buyer group 2: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ

●● companies
Description: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
Key Products: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
πŸ”’ View all companies in this group
Request Free Trial Now β†’
πŸ”’

Buyer group 3: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ

●● companies
Description: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
Key Products: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
πŸ”’ View all companies in this group
Request Free Trial Now β†’
πŸ”“ Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β†’

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to ADx Neurosciences

2.2 - Growth funds investing in similar companies to ADx Neurosciences

πŸ”’ View all growth equity funds with complete profiles
Start Free Trial β†’

4 - Top valuation comps for ADx Neurosciences

4.2 - Public trading comparable groups for ADx Neurosciences

πŸ”“ Unlock all public trading comparable groups with complete valuation data
Start Free Trial β†’

4.3 - M&A Transactions similar to ADx Neurosciences

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
πŸ”’ View all M&A transactions with complete deal terms
Request Free Trial Now β†’

Frequently Asked Questions

About ADx Neurosciences

What does ADx Neurosciences do?

ADx Neurosciences is a provider of proprietary biomarker assays and antibody solutions for neurodegenerative diseases, enabling early detection of Alzheimer’s, Parkinson’s and traumatic brain injury. Delivers custom and monoclonal antibodies (Amyloid-beta, Tau, Synuclein), pharma and IVD solutions from antibody to qualified assay and automated kits, and co-develops commercial immunoassays for clinical and drug development.

Who are ADx Neurosciences's competitors?

ADx Neurosciences's competitors and similar companies include Rapport Therapeutics, Nautilus Neurosciences, Cosman Medical, Claret Medical, and Psyadon.

Where is ADx Neurosciences headquartered?

ADx Neurosciences is headquartered in Belgium.

How many employees does ADx Neurosciences have?

ADx Neurosciences has 1,000 employees πŸ”’.

When was ADx Neurosciences founded?

ADx Neurosciences was founded in 2010 πŸ”’.

What sector and industry vertical is ADx Neurosciences in?

ADx Neurosciences is in the Enterprise Software πŸ”’ sector and industry

M&A Buyers & Acquirers for ADx Neurosciences

Who are the top strategic acquirers in ADx Neurosciences's sector and industry

Top strategic M&A buyers and acquirers in ADx Neurosciences's sector include β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, and β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ πŸ”’.

Which M&A buyer groups are most relevant for ADx Neurosciences?

Top strategic M&A buyers groups and sectors for ADx Neurosciences include β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ , β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, and β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ πŸ”’.

Financial Investors investing in ADx Neurosciences's sector and industry vertical

Which are the top PE firms investing in ADx Neurosciences's sector and industry vertical?

Top PE firms investing in ADx Neurosciences's sector and industry vertical include β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, and β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ πŸ”’.

Who are the top buyout funds acquiring in ADx Neurosciences's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in ADx Neurosciences's sector and industry vertical include β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, and β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ πŸ”’.

Who are the top growth equity funds investing in companies in ADx Neurosciences's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to ADx Neurosciences include β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, and β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ πŸ”’.

Valuation benchmarks of companies in ADx Neurosciences's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for ADx Neurosciences?

The key public trading comparables and valuation benchmarks for ADx Neurosciences include β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, and β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ πŸ”’.

Which are the key trading comparable groups for ADx Neurosciences for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for ADx Neurosciences with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in ADx Neurosciences's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for ADx Neurosciences with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in ADx Neurosciences's' sector and industry vertical?

Access recent funding rounds and capital raises in ADx Neurosciences's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for ADx Neurosciences

Launch login modal Launch register modal